Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nuo Therapeutics Inc (OTCQX US:NUOT)

0.1996
Delayed Data
As of 3:45pm ET
 +0.0012 / +0.60%
Today’s Change
0.14
Today|||52-Week Range
0.48
-42.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$24.9M

Company Description

Nuo Therapeutics, Inc. is a regenerative therapy company, developing and commercializing innovative autologous therapies that promote healing by harnessing the innate regenerative capacity of platelets and adult stem cells. It currently has a growing commercial operation, and a robust clinical pipeline seeking to exploit large market opportunities with unmet medical needs. The company's current commercial offerings are centered rich plasma platform technology, and primarily include the angel whole blood separation system and the autologel system. These products primarily address the areas of wound care, and support of healing and recovery following orthopedic procedures. The company was founded on April 29, 1998 and is headquartered in Gaithersburg, MD.

Contact Information

Nuo Therapeutics, Inc.
207A Perry Parkway
Gaithersburg Maryland 20877
P:(866) 298-6633
Investor Relations:

Employees

Shareholders

Individual stakeholders16.71%
Mutual fund holders--
Other institutional--

Top Executives

Martin P. RosendaleChief Executive Officer
Patrick Paul VanekVice President-Operations
David Emerson JordenChief Financial Officer
Peter A. ClausenChief Science Officer
Carelyn P. FyllingVice President-Professional Services